Press Releases

iXPressGenes experiment launches to the International Space Station

HudsonAlpha Associate Growing Crystals in Space

Huntsville, Ala. – An experiment by HudsonAlpha associate company iXPressGenes launched today onboard the SpaceX Dragon capsule en route to the International Space Station.

Synthetic and bioengineering company iXpressGenes was one of the first recipients of a grant from the Center for the Advancement of Science in Space to send an experiment on advancing protein crystallization in microgravity to the ISS national laboratory.

Pond-dwelling powerhouse’s genome points to its biofuel potential

HudsonAlpha’s Jeremy Schmutz a key contributor to milestone discovery

Duckweed is a tiny floating plant that’s been known to drive people daffy. It’s one of the smallest and fastest-growing flowering plants that often becomes a hard-to-control weed in ponds and small lakes. But it’s also been exploited to clean contaminated water and as a source to produce pharmaceuticals. Now, the genome of Greater Duckweed (Spirodela polyrhiza) has given this miniscule plant’s potential as a biofuel source a big boost. In a paper published February 19, 2014 in the journal Nature Communications, researchers from Rutgers University, the Department of Energy Joint Genome Institute, HudsonAlpha Institute for Biotechnology and several other facilities detailed the complete genome of S. polyrhiza and analyzed it in comparison to several other plants, including rice and tomatoes.

Registration opens for HudsonAlpha-Science’s 2014 Conference on ImmunoGenomics

International conference brings together preeminent leaders and thinkers at the intersection of genomics and immunology

HUNTSVILLE, Ala., Feb. 14 — Registration opens today for the HudsonAlpha-Science 2014 Conference on ImmunoGenomics, to be held Sept. 29–Oct. 1 on the HudsonAlpha biotechnology campus in Huntsville, Ala. 

The event offers a dynamic program covering the major themes of this emerging scientific field.  ImmunoGenomics sits at the heart of the movement toward ‘personalized’ medicine and the use of DNA sequencing to improve disease diagnosis and treatment.  More information, including registration and sponsorships, can be found at the event site: http://haig.aaas.org.

New method developed for ranking disease-causal mutations within whole genome sequences

Approach distills vast amounts of data into a single score

Seattle, Wash. and Huntsville, Ala.—Researchers from the University of Washington and the HudsonAlpha Institute for Biotechnology have developed a new method for organizing and prioritizing genetic data. The Combined Annotation–Dependent Depletion, or CADD, method will assist scientists in their search for disease-causing mutation events in human genomes.
 
The new method is the subject of a paper titled “A general framework for estimating the relative pathogenicity of human genetic variants,” published in Nature Genetics.

Conversant Bio Releases Normal Bone Marrow E-Book

Published by Global Leader in Tissue and Cell Samples, Guide Offers Key Information on Normal Bone Marrow to Help Researchers

Huntsville, AL—January 28, 2014 — Conversant Bio, a global leader in supplying the highest-quality human tissue and viable cell samples, today announced it is publishing a guide to the basics of normal bone marrow and how it’s used in research. The e-book A Researcher’s Guide to Normal Bone Marrow, is available as a free download at http://www.conversantbio.com/a-researchers-guide-to-normal-bone-marrow/.

CFDRC-developed SynVivo® recognized among “Top 10 Innovations of 2013” by The Scientist

HUNTSVILLE, Ala. December 4, 2013 – CFD Research Corporation-developed SynVivo® microfluidic cell-based assay platform has been recognized as one of the "Top 10 Innovations of 2013" by The Scientist magazine. SynVivo enables faster, more efficient drug development by combining the control of in vitro testing with the realism of in vivo studies. 
 

MVW Nutritionals sees healthy start

Company’s supplements and vitamins support cystic fibrosis community

HUNTSVILLE, Ala. -- “Just yesterday, I had a call from a CF mom,” said Mike Walters, one of three principals of start-up MVW Nutritionals, LLC. “Her son wouldn’t take his vitamin because the manufacturer had changed the flavor. Getting him to take the new vitamin had become a battle.” The frustrated mother contacted a cystic fibrosis care center and was referred to MVW. “Today, a bottle of vitamins is going out the door,” Walters said. He sent a free, one-month supply. “I asked only that she pay the shipping and also asked her to contact me again if her son didn’t like it because there are several other products.”
 

Basic research yields knowledge of transcription factor binding sites

New, robust methodology is side benefit

HUNTSVILLE, Ala. --Whether or not a gene is expressed, that is, whether it is turned on or turned off, is in part controlled by a group of proteins called transcription factors. Scientists in the Myers lab at the HudsonAlpha Institute recently published results of a basic research project undertaken to better understand mechanisms that determine cell type-specific transcription factor binding.
 

HudsonAlpha guidebook featured in national education publication

“Too new for textbooks,” means timely and exciting content for life sciences classrooms

American Biology Teacher, a print and online journal for K-16 biology teachers, features HudsonAlpha’s Biotechnology Discoveries and Applications guidebook in the September issue.

HudsonAlpha and UAB researchers team to identify lupus disease pathways

Study of the epigenome searches for disease triggers

Using genome-wide analyses, researchers at the HudsonAlpha Institute for Biotechnology along with clinical and research partners at the University of Alabama at Birmingham, have released the largest published study that examines epigenetic risk pathways for lupus. Lupus is an autoimmune disease that occurs primarily in women and is known to have both genetic and epigenetic causes. The disease may affect various parts of the body, especially the skin, joints, blood and kidneys.